Auto-immune-like cone dystrophy

Purpose: To describe rapid loss of cone vision in an adult due to putative auto-immune rejection. Methods: Clinical and electrophysiological examination, including full-field and multi-focal electroretinograms (ERGs), were used to assess retinal function. Serum was analyzed for antibodies to retinal antigens. Results: The patient lost cone vision in the course of several months while rod vision remained unaffected. Initially short wavelength (S) cone function appeared more resistant to the degeneration. Cancer associated retinal antibodies were present in the sera of the patient but no cancer has been found. Conclusion: Rapid loss of cone function can occur in an adult without a concomitant neoplasm although serum antibodies to retinal antigens suggest an autoimmune cause.     

Autosomal recessive frontotemporal pachygyria

Pachygyria is a cortical malformation that results from the abnormal migration of neurons. Regions of the brain with pachygyria have an abnormally thick cortex that lacks normal folding and has deficient layering. We describe three siblings, born to nonconsanguineous Mexican parents, who have bilateral frontotemporal pachygyria without polymicrogyria. The pachygyria is accompanied by moderate mental retardation, esotropia, and either hypertelorism or telecanthus. They are otherwise morphologically normal and do not have microcephaly. Two experienced a single seizure in infancy. The characteristic phenotype present in this family suggests a new genetic syndrome that is likely inherited as an autosomal recessive trait.     

The current status of allied dental faculty: a survey report

Allied dental program directors have expressed increasing concerns about possible current and future shortages of allied dental educators. As a result, the ADEA Board of Directors created a task force to investigate the current status of allied dental faculty, including the degree of cultural diversity, and to identify whether current and/or potential future shortages of educators exist. A survey was sent to all accredited allied dental program directors. Results indicated that a current faculty shortage exists for dental assisting and dental hygiene programs, with a projected greater future shortage for all allied dental education disciplines, primarily as a result of retirement of current faculty members. The data collected also revealed a lack of diversity in allied dental faculties, especially in dental hygiene and dental assisting programs. Recommendations for action steps included investigating: 1) the use of technology to provide the faculty expertise necessary to allow more affordable quality education in almost any location and to maximize available resources; 2) alternative ways to reward faculty; 3) loan forgiveness as an incentive for exemplary graduates to pursue educational career goals; 4) an ongoing database to monitor the status of allied dental educators; and 5) best practices in higher education to attract a more diverse student body and faculty in terms of gender, ethnicity, and race.     

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

BACKGROUND: The treatment of schizoaffective disorder is often complicated by the variety of symptoms that contribute to its pathology. Data from a large study (n=725), which included schizoaffective patients to assess the effect of long-acting risperidone, are presented. METHOD: A multicenter, open-label study enrolled non-acute, clinically stable patients with schizoaffective disorder (n=110). Patients on a stable dose of antipsychotic for at least 4 weeks at study entry were switched to long-acting risperidone every 2 weeks for 50 weeks. RESULTS: Mean Positive and Negative Syndrome Scale (PANSS) total scores (+/-S.E.) improved significantly (p<0.001) at each measured time point, including endpoint (-9.0+/-1.6), compared with baseline. Significant reductions were observed on mean PANSS cluster scores for both anxiety/depression (-1.3+/-0.4, p<0.001) and uncontrolled hostility/excitement (-0.7+/-0.3, p<0.05). In addition, scores improved significantly for positive symptoms (-2.2+/-0.5, p<0.001), negative symptoms (-3.1+/-0.5, p<0.001), and disorganized thoughts (-1.7+/-0.4, p<0.001). The overall subjective score of movement disorders was low at baseline (3.6+/-4.1) and had significantly decreased at endpoint (2.75; p<0.05). Patients were previously treated with antipsychotics for 398+/-790 days before being switched to long-acting risperidone. LIMITATIONS: Although this was a 50-week study, which included over 100 patients with schizoaffective disorder, limitations include the open-label design and that it was not designed specifically to assess patients with this disorder. PANSS symptom domains previously defined by factor analytic methods were used for mood symptom measures. No specific mood symptom scales were administered in this study. CONCLUSION: Patients with schizoaffective disorder, considered stable on their antipsychotic medication at study entry, experienced additional significant clinical improvements and minimal side effects with injections of long-acting risperidone over a 50-week study period.